Healthcare providers' perspectives on expedited partner therapy for chlamydia: a qualitative study

Sexually Transmitted Infections
Elian A RosenfeldElizabeth Miller

Abstract

Expedited partner therapy (EPT) effectively reduces rates of reinfection with chlamydia and increases the number of partners treated for the infection. Healthcare provider (HCP) provision of EPT is low. The objective of this qualitative study was to understand HCP views and opinions regarding the use of EPT in a state where EPT is permissible but underused. Using a purposive sampling strategy to include diverse HCPs who treat young women at risk for chlamydia, 23 semistructured, in-depth interviews were conducted between October and December 2013. The interviews included questions about knowledge, attitudes, experiences with, and barriers and facilitators regarding the use of EPT. Many respondents report using EPT and believe the practice is beneficial for their patients. Most providers were unaware of their colleagues' practices and had limited knowledge regarding institutional policies around EPT. HCPs noted a variety of barriers, such as fear of liability, confusion around the legal status of EPT and not being able to counsel patients' partners that make routine use of this practice a challenge. Facilitators of EPT include speaking on the phone with patients' partners and establishing legislation enabling EPT. This is the fi...Continue Reading

References

Jun 27, 2000·Journal of Women's Health & Gender-based Medicine·C WalshK Irwin
Oct 31, 2002·American Journal of Public Health·Janet S St LawrenceJami S Leichliter
Jan 26, 2005·Sexually Transmitted Diseases·Matthew HogbenMatthew R Golden
Feb 16, 2005·American Journal of Preventive Medicine·Linda M Niccolai, Diana M Winston
Feb 18, 2005·The New England Journal of Medicine·Matthew R GoldenKing K Holmes
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patricia KissingerThomas A Farley
Jun 25, 2008·International Journal of STD & AIDS·Sivapatham Shivasankar, Rachel Challenor
Sep 10, 2008·Sexually Transmitted Diseases·Richard C Goldsworthy, Dennis J Fortenberry
Jul 21, 2009·Sexually Transmitted Diseases·Christina B HosenfeldHeidi M Bauer
Jul 12, 2011·International Journal of STD & AIDS·M M TaylorB England
Jul 23, 2013·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Mj TuneuC The Partner Notification Study Group

❮ Previous
Next ❯

Citations

Feb 9, 2017·Journal of Pediatric and Adolescent Gynecology·Kathryn E Gannon-LoewAndrea E Bonny
Jul 15, 2017·Journal of American College Health : J of ACH·Sara B Oswalt, Heather P Eastman-Mueller
Feb 9, 2018·Pharmacy : Journal of Pharmacy, Education and Practice·Helen WoodSajni Gudka
Jan 15, 2020·Sexually Transmitted Diseases·Michelle Carman-McClanahan, Megan McCool-Myers
Jan 16, 2016·Sexually Transmitted Diseases·Julia Ann SchillingerMatthew R Golden
Sep 13, 2018·American Journal of Public Health·Cornelius D JamisonOkeoma Mmeje
Oct 13, 2020·Sexually Transmitted Diseases·Michelle L PickettAmy L Drendel
Aug 24, 2021·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Cornelius D JamisonOkeoma Mmeje
Jun 13, 2021·Sexually Transmitted Diseases·Jennifer Denise SuarezEmily Adhikari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.